Cited by 47Acute Kidney Injury ResearchRenal Diseases and GlomerulopathiesRenal Transplantation Outcomes and Treatments

Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis

Open access
Moledina, Dennis G, Wilson, F Perry, Kukova, Lidiya, Obeid, Wassim, Luciano, Randy, Kuperman, Michael, Moeckel, Gilbert W, Kashgarian, Michael +3 more·2021·Nephrology Dialysis Transplantation

Abstract

Background: We previously demonstrated that urine interleukin (IL)-9 and tumor necrosis factor (TNF)-α can distinguish acute interstitial nephritis (AIN) from other causes of acute kidney injury. Here we evaluated the role of these biomarkers to prognosticate kidney function in patients with AIN. Methods: In a cohort of participants with biopsy-proven, adjudicated AIN, we tested the association of histological features and urine biomarkers (IL-9 and TNF-α) with estimated glomerular filtration rate measured 6 months after diagnosis (6 m-eGFR) controlling for eGFR before AIN and albuminuria. We also evaluated subgroups in whom corticosteroid use was associated with 6 m-eGFR. Results: In the 51 (93%) of the 55 participants with complete data, median (interquartile range) eGFR before and 6 m after AIN were 41 (27–69) and 28 (13–47) mL/min/1.73 m2, respectively. Patients with higher severity of interstitial fibrosis had lower 6 m-eGFR, whereas those with higher tubulointerstitial infiltrate had higher 6 m-eGFR. IL-9 levels were associated with lower 6 m-eGFR only in the subset of patients who did not receive corticosteroids [6m-eGFR per doubling of IL-9, −6.0 (−9.4 to −2.6) mL/min/1.73 m2]. Corticosteroid use was associated with higher 6 m-eGFR [20.9 (0.2, 41.6) mL/min/1.73 m2] only in those with urine IL-9 above the median (>0.66 ng/g) but not in others. Conclusions: Urine IL-9 was associated with lower 6 m-eGFR only in participants not treated with corticosteroids. Corticosteroid use was associated with higher 6 m-eGFR in those with high urine IL-9. These findings provide a framework for IL-9-guided clinical trials to test efficacy of immunosuppressive therapy in patients with AIN.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfaa169

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Moledina et al. observed higher levels of urinary CXCL9, IL-9 and TNF-α in patients with AIN.

    “Despite the findings of Moledina et al. [60, 62, 94], who observed a higher level of urinary C-X-C motif ligand 9 (CXCL9), interleukin-9 (IL-9) and tumor necrosis factor-α (TNF-α) levels in patients with AIN”

    From The diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review (2024) · cites this paper as [94]

    The Discussion (page unavailable) says urinary IL-9 and TNF-α were previously shown to distinguish AIN from other causes of acute kidney injury. This paper does not report the claimed higher urinary CXCL9 level, so it supports only the IL-9 and TNF-α portion of the sentence. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [7]7. Berney-Meyer L, Hung N, Slatter T et al. Omeprazole-induced acute inter- stitial nephritis: a possible Th1-Th17-mediated injury? Nephrology (Carlton) 2014; 19: 359-365
  2. [19]19. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney in- jury. Kidney Inter Suppl 2012; 2: 1-138

Cited by

Sorted by citations

Authors
Moledina, D. G., Wilson, F. P., Kukova, L., Obeid, W., Luciano, R., Kuperman, M., Moeckel, G. W., Kashgarian, M., Perazella, M. A., Cantley, L. G., & Parikh, C. R.
Affiliations
  • Yale University (US)
  • Albert Einstein College of Medicine (US)
  • Johns Hopkins University (US)
  • Arkana Laboratories (US)
Corresponding author
Moledina, Dennis G
Venue
Nephrology Dialysis Transplantation
Published
2020-10-28
Volume
36
Issue
10
Pages
1851-1858
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W3096976558
Cited by
47
References
41
Citations by year
2026: 3 · 2025: 6 · 2024: 13 · 2023: 10 · 2022: 10 · 2021: 5
FWCI
3.93
Type
journal article
Language
en
Open access
Locations
  • Nephrology Dialysis Transplantation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (K23DK117065, T32DK007276, K24DK090203, R01DK113191, UG3DK114866, P30DK079310)
  • Department of Health and Human Services
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords
acute interstitial nephritis, TNF-α, urinary biomarkers, prognosis, estimated glomerular filtration rate, corticosteroid therapy, interstitial fibrosis, acute kidney injury, immunosuppressive therapy
MeSH terms
Glomerular Filtration Rate, Humans, Nephritis, Interstitial, Prognosis, Tumor Necrosis Factor-alpha, Interleukin-9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review